TITLE

Why do young women smoke? VI. A controlled study of nicotine effects on attention: pharmacogenetic interactions

AUTHOR(S)
Rigbi, A; Yakir, A; Sarner-Kanyas, K; Pollak, Y; Lerer, B
PUB. DATE
February 2011
SOURCE
Pharmacogenomics Journal;Feb2011, Vol. 11 Issue 1, p45
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
In prior studies we found that young, female smokers manifest poorer performance than non-smokers on attention-related tasks and that these findings can be moderated by variation in nicotinic acetylcholine receptor (nAChR) genes. We predicted that under controlled conditions (1) nicotine would improve functioning on attentional tasks in smokers who previously manifested relatively poor performance, and that (2) smokers who carry genetic variations associated with poorer attention performance would derive greater benefit from nicotine. To test these hypotheses, 31 young female smokers, who participated in our previous study, performed the Matching Familiar Figures Test (MFFT), Tower of London Test and Continuous Performance Task (CPT) in a double-blind, within-between subject design, placebo or nicotine (4 mg as gum) serving as the within factor and genetic profile as the between factor. Repeated measures ANCOVA controlling for attention deficit symptomatology, substance abuse and nicotine dependence showed better performance under nicotine among participants with higher levels of attention deficit symptoms (MFFT errors: P=0.04; CPT commissions: P=0.01) and nicotine dependence (CPT stability of response: P=0.04) and greater consumption of caffeine (CPT stability of response: P=0.04). An interactive effect of genetic profile was demonstrated for SNP rs2337980 in CHRNA7. These findings suggest that nicotine may have stronger short-term facilitating effects on attention in women who have more attention deficit symptoms and consume more nicotine and caffeine. This effect may be modified by a specific genetic make-up. Such individuals may be at increased risk for nicotine addiction and for greater difficulties in smoking cessation.
ACCESSION #
57544953

 

Related Articles

  • What's New in Nicotine & Tobacco Research ? Hébert, Richard // Nicotine & Tobacco Research;Feb2006, Vol. 8 Issue 1, p1 

    The article presents several research related nicotine and tobacco in the U.S. A team of researchers have tested an individualized, nurse-managed intervention called Smoke Free Baby and Me with rural-county pregnant smokers. Spanish researchers have revealed that the higher a smoker's education...

  • Association between smoking and retrospectively reported attention-deficit/hyperactivity disorder symptoms in a large sample of new mothers. Willoughby, Michael T.; Kollins, Scott H.; McClernon, F. Joseph // Nicotine & Tobacco Research;Mar2009, Vol. 11 Issue 3, p313 

    Introduction:: This study investigated the association between retrospectively reported attention-deficit/hyperactivity disorder (ADHD) symptoms experienced during childhood and five cigarette smoking–related outcomes in adulthood.

  • Tobacco Smoking in Individuals with Attention-Deficit Hyperactivity Disorder. Gray, Kevin M.; Upadhyaya, Himanshu P. // CNS Drugs;2009, Vol. 23 Issue 8, p661 

    The co-occurrence of attention-deficit hyperactivity disorder (ADHD) and nicotine dependence is common. Individuals with ADHD are more likely to initiate smoking and become dependent on nicotine than their non-ADHD counterparts, and recent evidence suggests that they may have more difficulty...

  • ADHD & Maternal Smoking.  // Pediatrics for Parents;1999, Vol. 18 Issue 5, p5 

    Reports on the results of a Swedish study on the link between maternal smoking and attention deficit hyperactivity disorder (ADHD).

  • Persistent Tobacco Use During Pregnancy and the Likelihood of Psychiatric Disorders. Flick, Louise H.; Cook, Cynthia A.; Homan, Sharon M.; McSweeney, Maryellen; Campbell, Claudia; Parnell, Lisa // American Journal of Public Health;Oct2006, Vol. 96 Issue 10, p1799 

    Objectives. We examined the association between psychiatric disorders and tobacco use during pregnancy. Methods, Data were derived from a population-based cohort of 744 pregnant African American and White low-income women living in urban and rural areas. The Diagnostic Interview Schedule was...

  • Attention-Deficit Hyperactivity Disorder (ADHD) symptoms and smoking patterns among participants in a smoking-cessation program. Lerman, Caryn; Audrain, Janet; Tercyak, Kenneth; Hawk Jr, Larry W.; Bush, Angelita; Crystal-Mansour, Susan; Rose, Christine; Niaura, Raymond; Epstein, Leonard H. // Nicotine & Tobacco Research;Nov2001, Vol. 3 Issue 4, p353 

    Previous research has suggested an increased liability to smoking among individuals with Attention-Deficit Hyperactivity Disorder (ADHD). This link is thought to be attributable, in part, to nicotine's beneficial effects on attention and performance. In the present study, we examined the...

  • A Pilot Study of Methylphenidate, Clonidine, or the Combination in ADHD Comorbid with Aggressive... Connor, Daniel F.; Barkley, Russell A.; Davis, Heather T. // Clinical Pediatrics;Jan2000, Vol. 39 Issue 1, p15 

    Summary: A pilot comparison of the safety and efficacy of methylphenidate (MPH) combined with clonidine, clonidine monotherapy, or MPH monotherapy in 6- to 16-year-old children diagnosed with attention deficit hyperactivity disorder (ADHD) and comorbid aggressive oppositional defiant disorder or...

  • Pharma: Clinic Roundup.  // BioWorld Today;5/24/2012, p8 

    The article reports that the long-term maintenance efficacy of lisdexamfetamine dimesylate (LDX) in children and adolescents with attention deficit hyperactivity disorder (ADHD) has been demonstrated in the Phase III trial of the drug from Shire Plc.

  • Randomised Controlled Study-efficacy of Clonidine versus Carbamazepine in Children with ADHD. Vrinda Nair; S. Mahadevan // Journal of Tropical Pediatrics;Apr2009, Vol. 55 Issue 2, p116 

    Background: Attention deficit hyperactivity disorder (ADHD) is one of the most common childhood psychiatric disorder with a prevalance of 8–12%. Even though psychostimulants remain the treatment of choice, its cost and availability in developing countries limits the usage of the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics